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In Brief
 
Bacterial Cell Death
 
Streptomyces
 
 cell death, which occurs as the bacteria de-
velop fruiting bodies and form spores, has been dismissed
as nonspecific autolysis caused by cell wall degradation.
Now Migulez et al. (page 515) show that the cell death is
complex: it occurs at two different times in two different
locations and as a series of defined steps that leave the cell
wall intact.
 
Streptomyces
 
 grow first along and through their growth
medium, as multinucleoid hyphae. This substrate myce-
lium subsequently forms stalks that rise above the growth
medium. Parts of the aerial hyphae septate to form spores.
Cell death occurs in two major waves. As aerial hyphae
are growing, nucleoids at the level of the growth medium
begin degenerating. Sporulation then starts, by which time
the substrate mycelium is dead and a second death process
is starting in the aerial hyphae, from the bottom up. Two
days later all cells are either dead or spores.
The first sign of degeneration is a loosening of the fibril-
lar DNA structure. The nucleoid and then cytoplasm be-
come less electron-dense, ending with a nucleoid that is
electron-translucent and has fibrillar structure. Only at the
end of this process does the plasma membrane retract
from the cell wall and form vesicles. The cell wall is left in-
tact, probably as both a mechanical support and nutrient
conductor for the aerial hyphae.
A genetic dissection of the death process would seem to
be the next logical step. This may uncover a link to pro-
grammed cell death in other organisms, as the 
 
Streptomy-
ces
 
 genome contains distant relatives of some mammalian
apoptosis genes (Aravind, L., V.M. Dixit, and E.V. Koo-
nin. 1999. 
 
Trends Biochem. Sci.
 
 24:47Ð53).
 
Myogenin Controls Muscle Metabolism
 
Fast muscle fibers rely on glycolysis for the intense but
short-lived bursts of activity needed for throwing a ball or
regaining balance. But muscles that are used for activities
such as standing need greater endurance. These slow mus-
cle fibers use oxidative metabolism for a less intense,
longer-lived supply of energy. Endurance training may
cause muscle fibers to change from a glycolytic to oxida-
tive pattern of energy usage, and now Hughes et al. report
that overexpression of the muscle differentiation factor
myogenin can induce just such a switch (page 633).
ÒThis makes myogenin one of the prime candidates for
the pathway connecting electrical activity and phenotype,Ó
says senior author Kristian Gundersen. The other links in
this pathway are not known, although a number of the
genes for mitochondrial metabolic enzymes have se-
quences that could be used for direct binding and regula-
tion by myogenin.
 
Catenin as an Inhibitor
 
Catenins are known primarily as linkers from cadherins to
actin, a pro-adhesive role, but now Aono et al. report that
 
p120
 
ctn
 
 acts as an inhibitor of cadherin-based adhesion
(page 551).
Aono et al. start with colon carcinoma cells that have all
the components for E-cadherinÐdependent adhesion, but
somehow remain dispersed. Treatment of the cells with
the protein kinase inhibitor staurosporine, or with small
amounts of trypsin, induce E-cadherinÐdependent adhe-
sion and a coincident shift in the mobility of p120
 
ctn
 
. The
mobility shift is consistent with a dephosphorylation of
p120
 
ctn
 
.
The binding site for p120
 
ctn
 
 is a juxtamembrane portion
of cadherin that has previously been implicated in adhe-
sion inhibition. Consistent with that theory, a truncated
p120
 
ctn
 
 that still binds cadherin (and presumably displaces
the full-length p120
 
ctn
 
) can restore cell adhesion to the car-
cinoma cells. Furthermore, once the p120
 
ctn
 
-binding site is
removed from an N-cadherin construct, the construct can
induce N-cadherinÐdependent adhesion of the carcinoma
cells.
A loss of cell adhesion may aid carcinoma cells in me-
tastasis and the avoidance of regulatory signals from
nearby cells. Normal cells may use p120
 
ctn
 
 as a reversible
adhesion switch for processes such as cell movement dur-
ing development. The proteins cleaved by trypsin are yet
to be identified, but they may be cell surface receptors in-
volved in such pathways.
 
Intermediate Filaments and Scar Formation
 
Astrocytes become reactive after an injury to the brain or
spinal cord, increasing their production of cytokines and
the intermediate filament proteins vimentin, nestin, and
glial fibrillary acidic protein (GFAP). Scar formation by
the reactive astrocytes is intact in mice that lack either vi-
mentin or GFAP, but is defective in mice that lack both
(Pekny et al., page 503).
The scar in the spinal cord of the double mutant is less
dense than normal, and includes fissures and blood. De-
 
fects in cortical scar formation are presumably the cause
 
of extensive bleeding and delayed healing in many of
the double mutant animals, which in some cases leads to
death.
Inhibition of IF production has been suggested as a ther-
apeutic approach to brain injury, as astrocytic scars may be
a barrier to neuron regrowth, but this study shows that the
scars may be important for protection. Intermediate fila-
ments may provide tensile strength to keep the scar to-
gether.
 
A Differentiation Factor Increases
Bone Resorption
 
Human bone is continuously being resorbed and replaced.
Control over this process of remodeling is exquisite; im-
balances often lead to excess bone resorption, the basis of
osteoporosis. On page 527, Burgess et al. report that a fac- 
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tor required for differentiation of precursor cells to form
the bone-resorbing cells, or osteoclasts, also directly in-
creases the resorbing activity of mature osteoclasts.
Burgess et al. suspected that the differentiation factor,
osteoprotegerin ligand (OPGL; also known as TRANCE,
ODF, and RANK ligand), was involved in osteoclast acti-
vation in addition to differentiation based on in vivo stud-
ies. In these studies, an OPGL antagonist caused remod-
eling changes that were too rapid to be explained by
differentiation effects alone, and OPGL treatment in-
duced bone resorption in animals without any apparent in-
crease in osteoclast number. These observations led Bur-
gess et al. to test the in vitro effects of OPGL on newly
isolated, mature osteoclasts. OPGL-treated osteoclasts re-
sorbed up to seven times more bone surface area than
untreated osteoclasts, with no increase in osteoclast cell
number.
OPGL acts, at least in part, by increasing the number of
resorption cycles per active osteoclast. This conclusion is
based on the observation of individual resorption events
by scanning electron microscopy. Many of these events are
 
clustered in groups in the sample treated with OPGL,
which suggests that single stimulated cells undergo multi-
ple resorption cycles. There are also more single resorp-
tion events, however, so OPGL may also activate previ-
ously inactive osteoclasts.
OPGL increases the number of cells with actin rings, the
structures that define a sealed zone at the bone surface,
within which bone-degrading protons and proteases can
be safely released. However, it is not clear whether the ex-
tra resorption events are primarily sequential (a small os-
teoclast performing multiple cycles) or simultaneous (a
large osteoclast with multiple actin rings).
The search for OPGL started with the discovery of
OPG, a soluble decoy receptor for OPGL that inhibits os-
teoclast differentiation. OPG is currently in clinical tri-
als for osteoporosis, and a small molecule antagonist of
OPGL may make another excellent clinical candidate.
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